The Lung Health Research & Medicine Revolution

Meeting the future needs of respiratory patients

Over the past century we have become adept at suppressing the symptoms of respiratory diseases but we have made little progress in curing them. Respiratory diseases are responsible for over 650,000 deaths annually in the EU and the burden on health systems is increasing as the population ages. A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases. All stakeholders in respiratory medicine are pooling their knowledge and resources to focus on risk factors to find cures, formulate new vaccines and develop cutting-edge technologies to tackle the burden of chronic respiratory diseases.

supported by a grant from astrazenecaand logo-boehringer-small

In order to promote productive collaborative models, regulators/ authorities in Europe need to create a regulatory framework that facilitates rather than blocks this new 'research eco-system'.

Luc Debruyne